Loading…
Operator of behavioral health and addiction treatment facilities, including inpatient psychiatric hospitals across the US.
Operator of behavioral health and addiction treatment facilities, including inpatient psychiatric hospitals across the US.
Is paid per patient day by government programs and private insurers, so occupancy and the mix of payers drive income. It grew through acquisitions and joint ventures with health systems, and sold its UK business in 2021 to focus on the US.
Moat: narrow (scale, regulatory licence). Large network of licensed psychiatric facilities amid limited supply of behavioral-health beds nationally.
Headquarters: Franklin, Tennessee · Founded: 2005 · Employees: 25,000
Size Acadia Healthcare (ACHC) is a United States Health Care company (Medical/Nursing Services) with a market value of $3.44B, the 1445th largest of 3,117 United States companies the cockpit tracks. Shares closed at $37.00 on 6 Nov 2026.
Performance Over six months the shares gained 46.9%, against +33.1% for the median peer and -1.1% for the United States market (cap-weighted) — 9th highest of 20 in its peer set.
Growth Revenue grew 4.3% over the last twelve months (peer median +11.3%); the operating margin is 10.1% (peer median 7.5%).
Valuation It trades at 18.7× forward earnings against a peer median of 46.0× (5th cheapest of 19).
Capital Return on invested capital runs 1.3 points below its cost of capital (6.9% WACC).
Credit Acadia Healthcare has 2 bonds outstanding ($925M), rated B+ by the agencies and trading like BB at a weighted spread of 142 bp.
Short interest Short interest is 22.5% of the free float (15 Oct 2026).
Next results Next results expected around 1 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $3.37B | $3.31B | $3.15B | $2.93B | $2.61B |
| Revenue growth | — | +5% | +8% | +12% | — |
| Gross profit | $548M | $583M | $712M | $683M | $604M |
| EBITDA | $535M | $577M | $672M | $639M | $564M |
| Net income | -$1.13B | -$1.10B | $256M | -$21.7M | $273M |
| Free cash flow | -$134M | -$440M | -$561M | $38.2M | $84.4M |
| Capital expenditure | $345M | $572M | $690M | $424M | $296M |
| Total debt | $2.57B | $2.65B | $2.10B | $1.51B | $1.54B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Acadia Healthcare ACHC | $3.44B | +47% | +4% | 10% | 18.7× | n/a |
| Universal Health Services UHS | $11.5B | +15% | +8% | 11% | 8.7× | -1.2% |
| Lifestance Health LFST | $5.26B | +79% | +20% | 5% | 62.6× | 37.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ACHC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +29.9% | +8.7% | 2nd highest of 21 |
| 6-month return | +46.9% | +33.1% | 9th highest of 20 |
| Distance from 52-week high | -6.0% | -14.4% | 4th highest of 21 |
| Revenue growth (TTM) | +4.3% | +11.3% | 9th lowest of 21 |
| Operating margin | 10.1% | 7.5% | 8th highest of 21 |
| Forward P/E | 18.7× | 46.0× | 5th cheapest of 19 |
| ROIC minus cost of capital | -1.3 pp | +1.4 pp | 9th lowest of 20 |
| EV / EBITDA | 11.3× | 14.9× | 2nd cheapest of 13 |
| Net debt / EBITDA | 4.5× | 2.9× | 5th most indebted of 16 |
| Bond spread | 142 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Acadia Healthcare ACHC | United States | $3.44B | +47% | +4% | 10% | 18.7× | n/a | n/a |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.50B | +26% | +17% | 24% | 51.5× | 32.2% | +11.8% |
| Fameglow 3774.HK | Hong Kong | $3.19B | n/a | +36% | 11% | n/a | 48.8% | +48.4% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.89B | -9% | -4% | 9% | 55.1× | 5.8% | +5.7% |
| Aveanna Healthcare AVAH | United States | $2.89B | +97% | +20% | 11% | 15.4× | 13.4% | +10.2% |
| Medicover MCOV-B.ST | Sweden | $4.14B | +36% | +6% | 7% | 38.3× | 20.8% | +20.2% |
| Option Care Health OPCH | United States | $4.74B | +54% | +4% | 6% | 15.6× | 1.5% | +13.2% |
| Pediatrix Medical MD | United States | $2.44B | +33% | +2% | 12% | 12.9× | -4.5% | +2.0% |
| Addus HomeCare ADUS | United States | $2.32B | +25% | +12% | 11% | 16.6× | 4.9% | +13.2% |
| AddLife ALIF-B.ST | Sweden | $2.29B | +25% | +2% | 8% | 40.5× | 21.6% | +14.6% |
| Lifestance Health LFST | United States | $5.26B | +79% | +20% | 5% | 62.6× | 37.8% | +30.4% |
| BillionToOne BLLN | United States | $5.38B | +54% | +90% | 11% | 144.4× | 26.8% | +90.1% |
| Concentra Group Holdings Parent CON | United States | $5.38B | +75% | +14% | 17% | 24.5× | 3.9% | +7.9% |
| NeoGenomics NEO | United States | $2.18B | +88% | +11% | -6% | 58.9× | n/a | n/a |
| Guangzhou Kingmed Diagnostics 603882.SS | China | $1.99B | +5% | -3% | 7% | 31.7× | 6.7% | -6.1% |
| RadNet RDNT | United States | $5.98B | +31% | +19% | 5% | 129.7× | 41.8% | +13.7% |
| Dian Diagnostics 300244.SZ | China | $1.97B | +11% | -5% | 9% | 25.2× | 2.4% | -1.1% |
| Hims & Hers Health HIMS | United States | $6.07B | -8% | +28% | 0% | 128.9× | 54.9% | +73.6% |
| Emeis EMEIS.PA | France | $1.94B | -30% | +4% | 3% | n/a | 21.3% | +8.5% |
| agilon health AGL | United States | $1.90B | +109% | 0% | -4% | 67.5× | n/a | n/a |
| GeneDx WGS | United States | $1.86B | +53% | +25% | -12% | 98.7× | n/a | n/a |
Acadia Healthcare has 2 bonds outstanding with $925M face value. The agencies rate it B+; its bonds trade like BB. Weighted yield 5.99%, a spread of 142 bp over government bonds.